In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients. - Wikidata - wikimedia - TriplyDB

In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.

In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.

http://www.wikidata.org/entity/Q35283144

about

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.In vitro activity of sparfloxacin compared with those of five other quinolones The cytotoxicity assessment of the novel latex urinary catheter with prolonged antimicrobial activity.Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.

P2860

Q34601561-E45C79EC-07D6-4752-8744-C00A6BAB76A6 Q35123308-A3046760-C09F-4BDA-914F-8932EB05B18F Q35137076-3F97CFF2-ABC9-484F-A061-320D15D17E71 Q35846849-3409FC7E-19E4-4037-8591-5AC99913C366 Q35867076-7A614445-08FB-4454-835D-C939877E6F9D Q39547089-63D4447D-03E0-4741-8D3A-3F90D0BA15A6 Q40088128-E52B3F73-72BC-4517-BB43-161DBAF488C6 Q41767493-3E91DCB1-11AD-41A5-B926-9AC7B8ADADE4

P2860

In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.

http://www.wikidata.org/entity/Q35283144

description

1990 nî lūn-bûn

@nan

1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

In vitro activity of sparfloxa ...... isolates from cancer patients.

@ast

In vitro activity of sparfloxa ...... isolates from cancer patients.

@en

type

label

In vitro activity of sparfloxa ...... isolates from cancer patients.

@ast

In vitro activity of sparfloxa ...... isolates from cancer patients.

@en

prefLabel

In vitro activity of sparfloxa ...... isolates from cancer patients.

@ast

In vitro activity of sparfloxa ...... isolates from cancer patients.

@en

P1433

Q35283144-9CE1297D-9ABE-4258-894B-608E7AC4AFCD

P1476

Q35283144-4BFF2993-4543-4D19-ABB1-3943608E79F4

P2093

Q35283144-076499B6-CC8C-46FF-98B4-46E70FEF07B9

Q35283144-2E858ADD-B8DB-4C55-9941-B5B44A277B05

Q35283144-32B107FB-5E90-4BDB-815F-48308A3C037D

Q35283144-89ED95D7-D2E5-4749-8805-C4FBA0A5B224

Q35283144-D84008F3-3A46-486D-8B5B-221051532D47

Q35283144-EF836B8B-C919-49E2-B9E7-7C11D5C2FCF7

P2860

Q35283144-09225F05-3866-4100-ADC7-0B97D8017790

Q35283144-4184280C-8CD4-4F77-9AF2-3A59C54B31DD

Q35283144-4917E5E2-85E6-4E73-B5C7-847AF10F99BB

Q35283144-5A230174-AC7E-4621-9D85-8D40809BDB0C

Q35283144-5BF17815-EEB2-44C5-9D37-4212CD9549C8

Q35283144-6880A8B4-002A-48E1-9E6A-758FD2C222F6

Q35283144-AA94FABE-77DF-42D8-947C-B9741333E35D

Q35283144-B4CD7DE0-A2D1-41D6-97D0-6CB35241C143

Q35283144-B96CDA97-F598-471F-9BEF-C8AAFD713508

Q35283144-D56CDD9D-CA1C-46F7-B695-39BE600649A3

P304

Q35283144-A64B8E2A-B18F-40C2-AE48-569EA4C537C0

P31

Q35283144-6B9463A4-3E96-4AEC-A842-0801BA3298F6

P356

Q35283144-B78DAB3B-BD57-48DD-8FD6-F242FC35800C

P407

Q35283144-B8526876-2207-4B97-A712-83FF9D31F0F0

P433

Q35283144-7A34F83E-7113-48A2-8BB3-E449C9E4E769

P478

Q35283144-F9044716-0646-4F40-8D90-1DA10F5ABB57

P577

Q35283144-AE377F99-2A2D-47A4-B380-D2B389546A71

P698

Q35283144-EB076E57-AC9C-4EF8-A91B-3731C2D5F370

P932

Q35283144-03BCACCE-BE9D-489A-B9AB-1112B2A7A576

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro activity of sparfloxa ...... isolates from cancer patients.

@en

P2093

B LeBlanc

http://www.w3.org/2001/XMLSchema#string

D H Ho

http://www.w3.org/2001/XMLSchema#string

G P Bodey

http://www.w3.org/2001/XMLSchema#string

H Nguyen

http://www.w3.org/2001/XMLSchema#string

K V Rolston

http://www.w3.org/2001/XMLSchema#string

M Messer

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

Method of reliable determination of minimal lethal antibiotic concentrations.

Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.

Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.

Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.

Pharmacokinetics of a novel quinolone, AT-4140, in animals.

In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus.

In vitro activity of AT-4140 against clinical bacterial isolates.

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

P304

2263-2266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.34.11.2263

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

1990-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2127348

http://www.w3.org/2001/XMLSchema#string

P932

172035

http://www.w3.org/2001/XMLSchema#string